Bitter Melon (Momordica Charantia) Supplementation Has no Effect on Hypercholesterolemia and Atherosclerosis in Mice

BioRxiv : the Preprint Server for Biology
S. MohammadmoradiSibu P Saha

Abstract

Momordica Charantia, commonly known as bitter melon, has been reported to ameliorate diet-induced obesity and dyslipidemia. However, the effects of M. Charantia on atherosclerosis have not been determined. This study investigated the effects of M. Charantia on diet-induced atherosclerosis in LDL receptor deficient mice. Female mice (6-8 weeks old) were fed a saturated fat-enriched diet. In group 1, mice were fed this diet alone, while mice in groups 2 and 3 were fed the diet supplemented with M. Charantia at either 0.1% or 1% wt/wt, respectively, for 12 weeks. No significant differences in body weights were observed between groups. There were also no significant differences in plasma cholesterol concentrations among the 3 groups. To determine the effects on atherosclerosis, lesion areas were measured on aortic intima by an en face technique. Neither of the doses of M. Charantia supplementation changed atherosclerosis development.

Related Concepts

Research
Genome
Oncologic
Human Genetics
Bio-Informatics
Oncology Field
Genomics
Computational Biology
Breeding
Science of Virology

Related Feeds

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.

Bioinformatics in Biomedicine (Preprints)

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest preprints on bioinformatics in biomedicine here.